"Entrez Gene: GSTM1 glutathione S-transferase M1"
Standard protocols often recommend cycling to prevent receptor desensitization, while lower doses may allow for more extended use without the same concerns about diminishing returns
This review provides a comprehensive summary of recent progress, opportunities, and challenges in targeting oxidative cell death for cancer therapy
As there are currently no means to correct G6PD deficiency, there is no treatment for the disease
As with any supplement, individuals should consult their healthcare practitioner to determine if it is appropriate for their personal wellness goals
Lower right panel : comparison of scopolamine with atropine, emphasizing greater CNS penetration and effects of scopolamine at therapeutic doses, including sedation and memory impairment, versus the relatively limited CNS activity of atropine, which is more associated with restlessness and confusion at higher doses